Cisplatin (Platinol)
General information
Class/mechanism: Platinum analog, alkylating-like, producing predominantly interstrand DNA crosslinks that are cell-cycle nonspecific.[1][2]
Route: IV
Extravasation: vesicant (concentration >=0.5 mg/mL)/irritant (concentration <0.5 mg/mL)
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
- Aggressive Non-Hodgkin lymphoma
- Anal cancer
- Basal cell and squamous cell skin cancer
- Bladder cancer
- Bone cancer
- Breast cancer
- Central nervous system (CNS) cancer
- Cervical cancer
- Esophageal cancer
- Gastric cancer
- Head and neck cancer
- Hepatobiliary cancer
- Hodgkin lymphoma
- Mantle cell lymphoma
- Melanoma
- Mesothelioma
- Multiple myeloma
- Neuroendocrine tumors
- Non-small cell lung cancer
- Ovarian cancer
- Pancreatic cancer
- Penile cancer
- Small cell lung cancer
- T-cell lymphoma
- Testicular cancer
- Thymoma
- Unknown primary
- Uterine cancer
Patient drug information
- Cisplatin (Platinol) patient drug information (Chemocare)[3]
- Cisplatin (Platinol) patient drug information (UpToDate)[4]
Also known as
Abiplatin, Axiplat, Biocisplatinum, Bioplatino, Blastolem, Blastolem RU, Briplatin, Brisplatin, C-Platin, CDDP, Ceplatin, Ciplatan, Ciplexal, cis-diamminedichloroplatinum III, CIS-GRY, cis-platinum, Cismaplat, Cispatin, Cisplamerck, Cisplan, Cisplasol, Cisplatex, Cisplatin, Cisplatin-AQ, Cisplatin-Ebewe I.A., Cisplatin-Teva, Cisplatin Comp, Cisplatin DBL, Cisplatine, Cisplatin Ebewe, Cisplatine Cytosafe, Cisplatine Dakota, Cisplatine Merck, Cisplatine Teva, Cisplatin FOT, Cisplatin Hexal, Cisplatin Lederle, Cisplatin Lens, Cisplatin Maruko, Cisplatin Mayne, Cisplatin NC, Cisplatino, Cisplatino Almirall, Cisplatino Asofarm, Cisplatino Deltafarma, Cisplatino Ferrer, Cisplatino Gador, Cisplatino Labinca, Cisplatino Martian, Cisplatino Microsules, Cisplatino Pharmacia, Cisplatino Teva, Cisplatin Pharmachemie, Cisplatin Pharmacia, Cisplatin Sandoz, Cisplatin Sanofi-Synthelabo, Cisplatin Solution, Cisplatinum, Cisplatyl, Cisteen, Citoplatino, Cytoplatin, Cytoplatin-AQ, DACP, DDP, Docistin, Elvecis, Fauldcispla, IA COR, Ifapla, JIN Shun, Kemoplat, Lederplatin, Lyoph.cisplatin, Metaplatin, Neoplat, Neoplatin, Nippon Kayaku Cisplatin, Noveldexis, NSC 119875, NUO XIN, Oncoplatin AQ, P&U Cisplatin, Placis, Platamin, Platamine, Platamine RTU, Platiblastin, Platiblastin-S, Platicis, Platidiam, Platikem, Platil, Platimit, Platin, Platinil, Platino II Filaxis, Platinol, Platinol AQ, Platinox, Platinoxan, platinum, Platiran, Platistil, Platistin, Platistine, Platosin, Pronto Platamine, Randa, Romcis, Shun KE DA, Sicatem, Sinplatin, Sisplanil, Tecnoplatin, Tisplal, Trav Cisplatin, or Unistin.
References
- Drug index
- Chemotherapy
- Platinum agents
- Alkylating agents
- Vesicant chemotherapy
- Irritant chemotherapy
- Anal cancer medications
- Basal cell and squamous cell skin cancer medications
- Bladder cancer medications
- Bone cancer medications
- Breast cancer medications
- Cancer of unknown primary medications
- Cervical cancer medications
- Esophageal cancer medications
- Gastric cancer medications
- Hepatobiliary cancer medications
- Hodgkin lymphoma medications
- Melanoma medications
- Mesothelioma medications
- Multiple myeloma medications
- Non-small cell lung cancer medications
- Ovarian cancer medications
- Pancreatic cancer medications
- Small cell lung cancer medications
- Testicular cancer medications
- Thymoma medications
- Uterine cancer medications